Case Reports: Follicular Carcinoma Presenting as Autonomous Functioning Thyroid Nodule and Containing an Activating Mutation of theTSH Receptor(T620I) and a Mutation of TheKi-RAS(G12C) Genes
- 1 May 2006
- journal article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 16 (5), 497-503
- https://doi.org/10.1089/thy.2006.16.497
Abstract
Most autonomous functioning thyroid nodules (AFTN) are benign thyroid follicular neoplasms. There are rare reports of malignant hot nodules, in which activating mutations of the TSH receptor (TSHR) were found. We report a case of follicular carcinoma presenting as an AFTN causing subclinical hyperthyroidism in a 64-year-old woman who had a 6-cm hot nodule in the left thyroid lobe. Genomic DNA was extracted from paraffin-embedded tissues from the tumor and extratumoral thyroid tissue. Sequence analyses revealed point mutations in two different genes: the normal ACC sequence at codon 620 of the TSHR gene was replaced by ATC, changing the threonine by isoleucine (T620I); and the wild-type GGT at codon 12 of Ki-RAS mutated to TGT, replacing glycine by cysteine (G12C). In transfection experiments the T620I mutant showed constitutive activity in terms of cyclic adenosine monophosphate (cAMP) production when permanently transfected in 3T3 cells. Here, we describe for the first time an activating mutation in 3codon 620 of the TSHR. In addition, the cancerous AFTN also contained a G12C Ki-RAS mutation. We hypothesize that the combination of these two mutations might have played an important role in both the hyperfunction of the tumor and the carcinogenetic process.Keywords
This publication has 38 references indexed in Scilit:
- The prognostic value of primary tumor size in papillary and follicular thyroid carcinomaCancer, 2005
- How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapyJournal of Endocrinology, 2004
- Does a Leu 512 Arg Thyrotropin Receptor Mutation Cause an Autonomously Functioning Papillary Carcinoma?Thyroid®, 2004
- Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases.Endocrine-Related Cancer, 2003
- A Phe 486 Thyrotropin Receptor Mutation in an Autonomously Functioning Follicular Carcinoma that was Causing HyperthyroidismThyroid®, 2000
- A Val 677 Activating Mutation of the Thyrotropin Receptor in a Hürthle Cell Thyroid Carcinoma Associated with ThyrotoxicosisThyroid®, 1999
- Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs Genes as a Cause of Toxic Thyroid AdenomasJournal of Clinical Endocrinology & Metabolism, 1997
- Detection of an Activating Mutation of the Thyrotropin Receptor in a Case of an Autonomously Hyperfunctioning Thyroid Insular CarcinomaJournal of Clinical Endocrinology & Metabolism, 1997
- Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformationJournal of Clinical Endocrinology & Metabolism, 1996
- v-myb Transformation of Xeroderma pigmentosum human fibroblasts: Overexpression of the c-Ha-ras oncogene in the transformed cellsExperimental Cell Research, 1991